Combination approaches to immunotherapy: the radiotherapy example (Q37773250)

22 August 2017

1 reference

title

Combination approaches to immunotherapy: the radiotherapy example (English)

1 reference

adaptive radiation therapy

22 August 2017

main subject

0 references

1 reference

1

1 reference

22 August 2017

Marka R Crittenden

2

1 reference

22 August 2017

publication date

1 November 2009

1 reference

22 August 2017

1 reference

22 August 2017

volume

1

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

1025-1037

1 reference

Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution

22 August 2017

cites work

1 reference

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

Changing concepts of cancer surgery: Surgery as immunotherapy

21 January 2018

1 reference

Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot study of safety, feasibility, and immune activation

21 January 2018

1 reference

Standard treatments induce antigen-specific immune responses in prostate cancer

21 January 2018

1 reference

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

21 January 2018

1 reference

An endotoxin-induced serum factor that causes necrosis of tumors

21 January 2018

1 reference

Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis

21 January 2018

1 reference

The controversial abscopal effect

21 January 2018

1 reference

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens

21 January 2018

1 reference

Cell surface antigens of human renal cancer defined by autologous typing

21 January 2018

1 reference

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

21 January 2018

1 reference

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

21 January 2018

1 reference

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells

21 January 2018

1 reference

Serological analysis of cell surface antigens of malignant human brain tumors

21 January 2018

1 reference

Serological analysis of human tumor antigens: molecular definition and implications

21 January 2018

1 reference

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

Tumor escape from immune response by variation in HLA expression and other mechanisms

21 January 2018

1 reference

Identification of human cancers deficient in antigen processing

21 January 2018

1 reference

Antigen presentation and T cell stimulation by dendritic cells

21 January 2018

1 reference

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

21 January 2018

1 reference

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

21 January 2018

1 reference

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

21 January 2018

1 reference

Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1

21 January 2018

1 reference

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway

21 January 2018

1 reference

Feeding dendritic cells with tumor antigens: self-service buffet or à la carte?

21 January 2018

1 reference

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

21 January 2018

1 reference

The induction of tolerance by dendritic cells that have captured apoptotic cells

21 January 2018

1 reference

Natural adjuvants: endogenous activators of dendritic cells

21 January 2018

1 reference

Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy

21 January 2018

1 reference

Intratumoral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinoma

21 January 2018

1 reference

Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression

21 January 2018

1 reference

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

A simple method to cure established tumors by inflammatory killing of normal cells

21 January 2018

1 reference

Effect of Irradiation on Immune Responses

21 January 2018

1 reference

The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation

21 January 2018

1 reference

Stereotactic body radiation therapy: a comprehensive review

21 January 2018

1 reference

Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor

21 January 2018

1 reference

From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies

21 January 2018

1 reference

Pulmonary hilar stereotactic body radiation therapy in the rat.

21 January 2018

1 reference

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo

21 January 2018

1 reference

Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells

21 January 2018

1 reference

How alpha beta T cells deal with induced TCR alpha ablation

21 January 2018

1 reference

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

21 January 2018

1 reference

Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population

21 January 2018

1 reference

Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells

21 January 2018

1 reference

Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma

21 January 2018

1 reference

Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution.

21 January 2018

1 reference

T cell homeostatic proliferation elicits effective antitumor autoimmunity

21 January 2018

1 reference

Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease

21 January 2018

1 reference

Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell priming

21 January 2018

1 reference

Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease

21 January 2018

1 reference

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.

21 January 2018

1 reference

Control of homeostatic proliferation by regulatory T cells

21 January 2018

1 reference

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

21 January 2018

1 reference

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

21 January 2018

1 reference

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

21 January 2018

1 reference

Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?

21 January 2018

1 reference

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

21 January 2018

1 reference

Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment

21 January 2018

1 reference

External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing

21 January 2018

1 reference

Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes

21 January 2018

1 reference

Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii protein

21 January 2018

1 reference

Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity

21 January 2018

1 reference

Gene therapy to manipulate effector T cell trafficking to tumors for immunotherapy.

21 January 2018

1 reference

Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells.

21 January 2018

1 reference

The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors

21 January 2018

1 reference

Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer

21 January 2018

1 reference

Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant

21 January 2018

1 reference

Intratumoral immunotherapy: using the tumour against itself

21 January 2018

1 reference

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

21 January 2018

1 reference

Toll-like receptor control of the adaptive immune responses

21 January 2018

1 reference

CpG oligodeoxynucleotide enhances tumor response to radiation

21 January 2018

1 reference

Localized irradiation of tumors prior to synthetic dsRNA therapy enhanced the resultant anti-tumor activity

21 January 2018

1 reference

From the analyst's couch: TLR-targeted therapeutics

21 January 2018

1 reference

The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines

21 January 2018

1 reference

A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities

21 January 2018

1 reference

TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors

21 January 2018

1 reference

Tumor production of angiostatin is enhanced after exposure to TNF-alpha

21 January 2018

1 reference

Inhibition of mTOR radiosensitizes soft tissue sarcoma and tumor vasculature

21 January 2018

1 reference

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy

21 January 2018

1 reference

Creating immune privilege: active local suppression that benefits friends, but protects foes.

21 January 2018

1 reference

Tregs and rethinking cancer immunotherapy

21 January 2018

1 reference

Checkpoint blockade in cancer immunotherapy

21 January 2018

1 reference

Enhancement of antitumor immunity by CTLA-4 blockade

21 January 2018

1 reference

OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor.

21 January 2018

1 reference

Anti-OX40 monoclonal antibody therapy in combination with radiotherapy results in therapeutic antitumor immunity to murine lung cancer

21 January 2018

1 reference

Cancer risk after renal transplantation in the nordic countries, 1964-1986

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.09.64

1 reference

22 August 2017

1 reference